Recent Updates
Recently added Catalysts
CGEM Positive Sentiment Score: 70/100

Cullinan Therapeutics to Participate in Upcoming Investor Conferences

Thursday, August 21, 2025 1 min read
Key Takeaway: Cullinan Therapeutics, Inc. will be participating in two significant investor conferences: the Cantor Global Healthcare Conference on September 4, 2025, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10, 2025. Both events will feature key executives, including the CEO and CMO, in discussions aimed at engaging with investors. Webcasts of these presentations will be available for a wider audience, promoting accessibility to their insights.

Market Sentiment Analysis

POSITIVE FACTORS

  • Cullinan Therapeutics is actively engaging with the investment community.
  • Participation in recognized conferences can enhance company visibility.
  • Webcasts of the events will be accessible, promoting transparency.

Full Press Release Details

CAMBRIDGE, Mass., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced its participation in the following upcoming investor conferences:
Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 in New York, NY on Thursday, September 4, 2025, at 2:10 p.m. ET.
Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY on September 10, 2025, at 8:30 a.m. ET.
Webcasts of the fireside chats will be available under the Events and Presentations section of the Company’s investor relations website at https://investors.cullinantherapeutics.com/events.
About Cullinan Therapeutics
nsmith@cullinantx.com
rweldon@cullinantx.com

Frequently Asked Questions

When is Cullinan Therapeutics participating in the Cantor Conference?

Cullinan Therapeutics will participate in the Cantor Global Healthcare Conference on September 4, 2025.

What time is the Morgan Stanley Conference fireside chat?

The Morgan Stanley Conference fireside chat is scheduled for September 10, 2025, at 8:30 a.m. ET.

Who will represent Cullinan Therapeutics at the conferences?

Nadim Ahmed and Dr. Jeffrey Jones will represent Cullinan Therapeutics.

Where can I find webcasts of the fireside chats?

Webcasts will be available on the Events and Presentations section of their investor website.

What is the focus of Cullinan Therapeutics?

Cullinan Therapeutics focuses on developing modality-agnostic targeted therapies.

Tags: CGEM Viatris Investor Conferences Healthcare Cullinan Therapeutics investor conferences Nadim Ahmed healthcare
Last updated: Aug 21, 2025